04/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:35 PM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:35 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
3:25 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
5:42 PM | Aerovate Therapeutics (Subject)
Atlas Venture Associates XII, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
6:18 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
6:24 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:31 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
8:22 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:15 PM | Aerovate Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/25/2024
3:12 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:35 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:37 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
2:28 PM | Aerovate Therapeutics (Subject)
Eldridge George A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:34 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
6:09 PM | Aerovate Therapeutics (Subject)
Sofinnova Venture Partners X, L.P. (Filed by)
| Form SC 13D/A | |
02/20/2024
5:38 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
3:28 PM | Aerovate Therapeutics (Subject)
TCG Crossover GP I, LLC (Filed by)
| Form SC 13G | |
02/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:45 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Pigot Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:29 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:11 PM | Aerovate Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/08/2024
6:59 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:17 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
4:50 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:24 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:10 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/07/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
7:04 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:13 PM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:17 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023
3:46 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
7:16 AM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
7:03 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
4:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
4:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
1:05 PM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
7:10 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
7:16 AM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
10:53 AM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2023
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
4:24 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2023
4:03 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2023
4:04 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/11/2023
4:06 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
2:35 PM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2023
6:55 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2023
1:22 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
06/21/2023
4:14 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dorval Allison (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Iwicki Mark T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Resnick Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
